Shantell Laketa Heiber

Array ( [id] => 3648352 [patent_doc_number] => 05605792 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic' [patent_app_type] => 1 [patent_app_number] => 8/445300 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5186 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605792.pdf [firstpage_image] =>[orig_patent_app_number] => 445300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4125639 [patent_doc_number] => 06033669 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-07 [patent_title] => 'Methods for generating cytotoxic T cells and treatment of diseases thereby' [patent_app_type] => 1 [patent_app_number] => 8/442378 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 32 [patent_no_of_words] => 23611 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/033/06033669.pdf [firstpage_image] =>[orig_patent_app_number] => 442378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3794653 [patent_doc_number] => 05726286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains' [patent_app_type] => 1 [patent_app_number] => 8/430633 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 15944 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726286.pdf [firstpage_image] =>[orig_patent_app_number] => 430633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777754 [patent_doc_number] => 05820870 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Recombinant human papillomavirus type 18 vaccine' [patent_app_type] => 1 [patent_app_number] => 8/409122 [patent_app_country] => US [patent_app_date] => 1995-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 11698 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/820/05820870.pdf [firstpage_image] =>[orig_patent_app_number] => 409122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784095 [patent_doc_number] => 05736318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Method and kit for evaluating human papillomavirus transformed cells' [patent_app_type] => 1 [patent_app_number] => 8/406248 [patent_app_country] => US [patent_app_date] => 1995-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6585 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736318.pdf [firstpage_image] =>[orig_patent_app_number] => 406248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3937475 [patent_doc_number] => 05871996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Retrovirus agents MSRV1 and MSRV2 associated with multiple sclerosis' [patent_app_type] => 1 [patent_app_number] => 8/384137 [patent_app_country] => US [patent_app_date] => 1995-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 17736 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871996.pdf [firstpage_image] =>[orig_patent_app_number] => 384137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320430 [patent_doc_number] => 06328975 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Recombinant swinepox virus' [patent_app_type] => 1 [patent_app_number] => 8/375992 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 70123 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328975.pdf [firstpage_image] =>[orig_patent_app_number] => 375992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067916 [patent_doc_number] => 05965138 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Recombinant chimeric virus and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/362240 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 28 [patent_no_of_words] => 64668 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965138.pdf [firstpage_image] =>[orig_patent_app_number] => 362240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697175 [patent_doc_number] => 05674499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Equine herpesvirus gene 15 mutants' [patent_app_type] => 1 [patent_app_number] => 8/360103 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6063 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674499.pdf [firstpage_image] =>[orig_patent_app_number] => 360103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837382 [patent_doc_number] => 05707629 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Immunogenic composition against equine herpesvirus type 1' [patent_app_type] => 1 [patent_app_number] => 8/341781 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 13328 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707629.pdf [firstpage_image] =>[orig_patent_app_number] => 341781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784506 [patent_doc_number] => 05840520 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Recombinant negative strand RNA virus expression systems' [patent_app_type] => 1 [patent_app_number] => 8/316439 [patent_app_country] => US [patent_app_date] => 1994-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 34 [patent_no_of_words] => 29941 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840520.pdf [firstpage_image] =>[orig_patent_app_number] => 316439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002555 [patent_doc_number] => 05961982 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Recombinant herpesvirus of turkeys and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/288065 [patent_app_country] => US [patent_app_date] => 1994-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 14 [patent_no_of_words] => 57081 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/961/05961982.pdf [firstpage_image] =>[orig_patent_app_number] => 288065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 477390 [patent_doc_number] => 07223411 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-29 [patent_title] => 'Herpesvirus replication defective mutants' [patent_app_type] => utility [patent_app_number] => 08/278601 [patent_app_country] => US [patent_app_date] => 1994-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 17411 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223411.pdf [firstpage_image] =>[orig_patent_app_number] => 08278601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324422 [patent_doc_number] => 06312699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Ligands added to adenovirus fiber' [patent_app_type] => 1 [patent_app_number] => 8/218369 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7864 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312699.pdf [firstpage_image] =>[orig_patent_app_number] => 218369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1137823 [patent_doc_number] => 06780630 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Parenteral immunization against rotavirus' [patent_app_type] => B1 [patent_app_number] => 07/911593 [patent_app_country] => US [patent_app_date] => 1992-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6937 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780630.pdf [firstpage_image] =>[orig_patent_app_number] => 07911593 [rel_patent_id] =>[rel_patent_doc_number] =>)